Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

755303

Sigma-Aldrich

3-Amino-2-fluoropropionic acid

95%

Synonym(s):

DL-2-Fluoro-β-alanine

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C3H6FNO2
CAS Number:
3821-81-6
Molecular Weight:
107.08
EC Number:
223-318-3
MDL number:
MFCD00041324
UNSPSC Code:
12352100
PubChem Substance ID:
329766489
NACRES:
NA.22

Quality Level

100

Assay

95%

form

solid

mp

240-245 °C

functional group

amine
carboxylic acid
fluoro

SMILES string

NCC(F)C(O)=O

InChI

1S/C3H6FNO2/c4-2(1-5)3(6)7/h2H,1,5H2,(H,6,7)

InChI key

OJQNRNQELNLWHH-UHFFFAOYSA-N

Related Categories

Pictograms

CorrosionExclamation mark
GHS05,GHS07

Signal Word

Danger

Hazard Statements

H302,H315,H318,H335

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

755303-VAR:
755303-BULK:
755303-100MG:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCP8809
MKCJ0281
MKCB3826
MKBX0060V
MKBK1527V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

J Murphy-Boesch et al.
Magnetic resonance in medicine, 37(3), 321-326 (1997-03-01)
An RF network and a dual-tuned surface coil are described for obtaining proton-decoupled, NOE enhanced 19F spectra from a whole body clinical imager operating at 1.5 Tesia. The network removes 19F frequency noise from the decoupler transmitter, and prevents preamplifier
András Vermes et al.
Fundamental & clinical pharmacology, 16(1), 39-47 (2002-03-21)
The aim of this study is to investigate whether fluorouracil (5-FU) could be responsible for bone-marrow depression occurring in fluorocytosine (5-FC) treated patients. Six 5-FC treated patients were included in this pilot study. Toxicity was monitored by means of thrombocyte
Yasuhide Yamada
Gan to kagaku ryoho. Cancer & chemotherapy, 33 Suppl 1, 37-41 (2006-08-11)
The pharmacokinetics and pharmacodynamics of oral S-1, a dihydropyrimidine dehydrogenase (DPD) inhibitory fluoropyrimidine, were compared with those of protracted venous infusion (PVI) of 5-fluorouracil (5-FU). In all, 10 patients with gastric cancer received PVI of 5-FU at a dose of
Katsuki Muneoka et al.
International journal of clinical oncology, 10(6), 441-443 (2005-12-22)
Cardiotoxicity is a rare complication occurring during 5-fluorouracil (5-FU) treatment for malignancies. We herein report the case of a 70-year-old man with 5-FU-induced cardiotoxicity, in whom a high serum level of alpha-fluoro-beta-alanine (FBAL) was observed. The patient, who had unresectable
Dennis W J Klomp et al.
Magnetic resonance in medicine, 50(2), 303-308 (2003-07-24)
Fluorine MR spectroscopy ((19)F MRS) is an indispensable tool for assessing the pharmacokinetics of fluorinated drugs. Since the metabolism of 5-fluorouracil (5FU), a frequently used cytotoxic drug, is expected to be different in normal liver and in tumor tissue, spatial
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service